Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_assertion type Assertion NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_head.
- NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_assertion wasGeneratedBy ECO_0000203 NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_provenance.
- NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_assertion wasDerivedFrom befree-2016 NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_provenance.
- NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_assertion SIO_000772 14968122 NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_provenance.
- NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_assertion evidence source_evidence_literature NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_provenance.
- NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_provenance.